Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study
- PMID: 25256594
- DOI: 10.1111/aogs.12516
Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study
Abstract
Objective: According to the recent theories on the ovarian cancer origin, any protective effect of tubal ligation may vary with histologic subtype of ovarian cancer. Furthermore, bilateral salpingectomy may represent an opportunity for surgical prevention of serous ovarian cancer.
Design: Nationwide register-based case-control study.
Setting: Denmark during 1982-2011.
Population: Cases were all Danish women diagnosed with epithelial ovarian cancer (n = 13 241) or borderline ovarian tumor (n = 3605) in the study period. Age-matched female population controls were randomly selected by risk set sampling. We required that cases and controls have no previous cancer and that controls have no previous bilateral oophorectomy.
Methods: Conditional logistic regression was used to estimate odds ratios and 95% confidence intervals, adjusting for potential confounders.
Main outcome measures: Epithelial ovarian cancer and borderline ovarian tumors stratified according to histology.
Results: Tubal ligation reduced overall epithelial ovarian cancer risk (odds ratios 0.87; 95% confidence interval 0.78-0.98). We observed significant risk variation according to histology (p = 0.003) with the strongest risk reductions associated with endometrioid cancer (odds ratios 0.66; 95% confidence interval 0.47-0.93) and epithelial ovarian cancer of "other" histology (odds ratios 0.60; 95% confidence interval 0.43-0.83). Tubal ligation was not associated with risk of borderline ovarian tumors. Finally, bilateral salpingectomy reduced epithelial ovarian cancer risk by 42% (odds ratios 0.58; 95% confidence interval 0.36-0.95).
Conclusions: We confirmed that tubal ligation reduces the risk of epithelial ovarian cancer and particularly endometrioid cancer. To our knowledge, this is the first observational publication to report on salpingectomy and ovarian cancer risk and our promising findings warrant further investigation.
Keywords: Ovarian cancer; borderline ovarian tumor; histologic subtype; salpingectomy; tubal ligation.
© 2014 Nordic Federation of Societies of Obstetrics and Gynecology.
Comment in
-
Surgical prevention of epithelial ovary cancer without oophorectomy: changing the future.Climacteric. 2016 Oct;19(5):417-8. doi: 10.1080/13697137.2016.1202914. Epub 2016 Jul 12. Climacteric. 2016. PMID: 27404380 No abstract available.
Similar articles
-
Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.Dan Med J. 2015 Jul;62(7):B5117. Dan Med J. 2015. PMID: 26183052
-
Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case-Control Study.Int J Cancer. 2013 Nov 15;133(10):2415-21. doi: 10.1002/ijc.28249. Epub 2013 Jul 9. Int J Cancer. 2013. PMID: 23650079 Free PMC article.
-
Risk of epithelial ovarian cancer Type I and II after hysterectomy, salpingectomy and tubal ligation-A nationwide case-control study.Int J Cancer. 2021 Oct 15;149(8):1544-1552. doi: 10.1002/ijc.33714. Epub 2021 Jul 7. Int J Cancer. 2021. PMID: 34152012
-
Salpingectomy as a means to reduce ovarian cancer risk.Cancer Prev Res (Phila). 2015 May;8(5):342-8. doi: 10.1158/1940-6207.CAPR-14-0293. Epub 2015 Jan 13. Cancer Prev Res (Phila). 2015. PMID: 25586903 Free PMC article. Review.
-
The Role of Opportunistic Bilateral Salpingectomy vs Tubal Occlusion or Ligation for Ovarian Cancer Prophylaxis.J Minim Invasive Gynecol. 2017 Mar-Apr;24(3):371-378. doi: 10.1016/j.jmig.2017.01.001. Epub 2017 Jan 10. J Minim Invasive Gynecol. 2017. PMID: 28087480 Review.
Cited by
-
The fallopian tube as origin of ovarian cancer: Change of diagnostic and preventive strategies.Cancer Med. 2020 Jan;9(2):421-431. doi: 10.1002/cam4.2725. Epub 2019 Nov 25. Cancer Med. 2020. PMID: 31769234 Free PMC article. Review.
-
Tubal Ligation and Age at Natural Menopause.Obstet Gynecol. 2019 Jun;133(6):1247-1254. doi: 10.1097/AOG.0000000000003266. Obstet Gynecol. 2019. PMID: 31135741 Free PMC article.
-
Models for measuring metabolic chemical changes in the metastasis of high grade serous ovarian cancer: fallopian tube, ovary, and omentum.Mol Omics. 2021 Dec 6;17(6):819-832. doi: 10.1039/d1mo00074h. Mol Omics. 2021. PMID: 34338690 Free PMC article. Review.
-
High-grade serous ovarian cancer 3 years after bilateral salpingectomy: A case report.Mol Clin Oncol. 2017 Feb;6(2):201-203. doi: 10.3892/mco.2016.1105. Epub 2016 Dec 12. Mol Clin Oncol. 2017. PMID: 28357094 Free PMC article.
-
Patients' and professionals' perspectives on implementation of opportunistic salpingectomy: a mixed-method study.BMC Health Serv Res. 2021 Jul 25;21(1):736. doi: 10.1186/s12913-021-06767-9. BMC Health Serv Res. 2021. PMID: 34303378 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical